Cyclacel Pharmaceuticals Statistics

Total Valuation

CYCC has a market cap or net worth of $46.52 million. The enterprise value is $49.40 million.

Market Cap	46.52M
Enterprise Value	49.40M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, after market close.

Earnings Date	May 20, 2025
Ex-Dividend Date	Apr 29, 2025

Share Statistics

CYCC has 12.96 million shares outstanding. The number of shares has increased by 529.44% in one year.

Current Share Class	12.96M
Shares Outstanding	12.96M
Shares Change (YoY)	+529.44%
Shares Change (QoQ)	+329.44%
Owned by Insiders (%)	1,803.06%
Owned by Institutions (%)	1.13%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.56
Forward PS	515.09
PB Ratio	-24.17
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1,148.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.59

Current Ratio	0.59
Quick Ratio	0.50
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-116.33%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	552.16%
Revenue Per Employee	$3,583
Profits Per Employee	-$934,333
Employee Count	12
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-782,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.12% in the last 52 weeks. The beta is 0.53, so CYCC's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-90.12%
50-Day Moving Average	4.39
200-Day Moving Average	9.81
Relative Strength Index (RSI)	42.95
Average Volume (20 Days)	463,374

Short Selling Information

The latest short interest is 2.70 million, so 20.80% of the outstanding shares have been sold short.

Short Interest	2.70M
Short Previous Month	27,619
Short % of Shares Out	20.80%
Short % of Float	n/a
Short Ratio (days to cover)	0.16

Income Statement

In the last 12 months, CYCC had revenue of $43,000 and -$11.21 million in losses. Loss per share was -$33.50.

Revenue	43,000
Gross Profit	43,000
Operating Income	-12.00M
Pretax Income	-22.73M
Net Income	-11.21M
EBITDA	-12.00M
EBIT	-12.00M
Loss Per Share	-$33.50

Full Income Statement

Balance Sheet

The company has $3.14 million in cash and n/a in debt, giving a net cash position of $3.14 million or $0.24 per share.

Cash & Cash Equivalents	3.14M
Total Debt	n/a
Net Cash	3.14M
Net Cash Per Share	$0.24
Equity (Book Value)	-2.17M
Book Value Per Share	-3.93
Working Capital	-2.59M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.99M
Capital Expenditures	n/a
Free Cash Flow	-7.99M
FCF Per Share	-$0.62

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-27,916.28%
Pretax Margin	-27,893.02%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $0.15, which amounts to a dividend yield of 4.18%.

Dividend Per Share	$0.15
Dividend Yield	4.18%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-529.44%
Shareholder Yield	-470.25%
Earnings Yield	-21.34%
FCF Yield	-15.21%

Dividend Details

Analyst Forecast

The average price target for CYCC is $11.00, which is 206.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.00
Price Target Difference	206.41%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 18, 2023. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Dec 18, 2023
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

CYCC has an Altman Z-Score of -160.47 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-160.47
Piotroski F-Score	1